Amgen Inc. Operating Leases, Future Minimum Payments, Due in Five Years
Amgen Inc. (AMGN) had Operating Leases, Future Minimum Payments, Due in Five Years of $56.00 million as of 2018-12-31, per its 10-K filed 2020-02-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2020-02-12
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $56.00M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $59.00M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $108.00M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $98.00M.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2018-12-31 | $56.00M 10-K · filed 2020-02-12 |
| 2017-12-31 | $59.00M 10-K · filed 2018-02-13 |
| 2016-12-31 | $108.00M 10-K · filed 2017-02-14 |
| 2015-12-31 | $98.00M 8-K · filed 2016-10-31 |
| 2014-12-31 | $139.00M 10-K · filed 2015-02-19 |
| 2013-12-31 | $86.00M 10-K · filed 2014-02-24 |
| 2012-12-31 | $67.00M 10-K · filed 2013-02-27 |
| 2011-12-31 | $65.00M 10-K · filed 2012-02-29 |
| 2010-12-31 | $88.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |